New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Though there are currently no clinical guidelines for their use, PRSs are being widely used in health care.
In a new practice guideline, the group also “strongly recommends” that NIPS be offered to patients to screen for fetal SCA.
The new practice guideline also recommends NIPS to screen for fetal sex chromosome aneuploidy.
Revised guidelines from the American Urological Association support limited use of the tests for certain prostate cancer patients.